ClinicalTrials.Veeva

Menu
R

RK Will Pty Ltd | Victoria Park, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tofacitinib
Methotrexate
Adalimumab
Tanezumab
Pentosan Polysulfate Sodium
BMS-986165
Filgotinib
Deucravacitinib

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 9 total trials

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (POETYK SLE-2)

The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe System...

Active, not recruiting
Systemic Lupus Erythematosus
Drug: Deucravacitinib
Other: Placebo

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared wi...

Enrolling
Osteoarthritis, Knee
Drug: Pentosan Polysulfate Sodium twice weekly
Drug: Placebo

Trial sponsors

Pfizer logo
A
Bristol-Myers Squibb (BMS) logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems